Clinical Trial: Innate Immunity Stimulation Via TLR9 in Early AD
Study Status: Completed
Recruit Status: RECRUITING
Condition: Mild Cognitive Impairment
Study Type: INTERVENTIONAL
Official Title: Phase 1 Clinical Trial of Innate Immunity Stimulation Via TLR9 in Early Alzheimer's Disease (AD)
Brief Summary:
This single-center, double-blind, placebo-controlled study will recruit in total 39 participants with either Mild Cognitive Impairment due to Alzheimer's disease (MCI) or Mild Alzheimer's disease dementia (mild AD).There will be 3 Dose levels.An initial cohort of 13 subjects will be randomized to a Dose level 1 (0.1 mg/kg vs. placebo) lasting 8 weeks.An additional 13 subjects will be recruited and randomized into Dose level 2 (0.25 mg/kg vs. placebo) for 8 weeks and 13 subjects for the last…
Read more